| Application no. and date | 13710851.0 (espacenet) (Federated) (European Patent Register), 20130319 | | Patent/reg. no. and date | DK/EP 2827860, 20161026 | | Publication date | 20150128 | | Priority no. and date | US 201261613187 P, 20120320 | | EP pub. no. and date |
EP 2827860 20150128 | | Effective date | | | Applicant/owner | Mereo BioPharma 1 Limited, 1 Cavendish Place
London W1G 0QF, GB | | Applicant ref. no. | P60267DK01 | | Inventor | FORD, Paul Andrew, c/o Novartis Pharmaceuticals UK Limited,
Wimblehurst Road,
Horsham, West Sussex,
Sussex RH12 5AB, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61P 11/00 (2006.01) | | Title | ANVENDELSE AF A PYRAZOL-DERIVAT I BEHANDLINGEN AF AKUTTE FORVÆRRINGER AF KRONISK OBSTRUKTIV LUNGESYGDOM | | Int. application no. | EP2013055730 | | Int. publication no. | WO2013139809 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
